Clinical trial
Treatment in Patients With Recurrent Infections and IgG Subclass Deficiency, and/or Deficient Anti-Polysaccharide Antibody Response
NCT00522821 is registered in ClinicalTrials.gov with Prothya Biosolutions as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment in Patients With Recurrent Infections and IgG Subclass Deficiency, and/or Deficient Anti-Polysaccharide Antibody Response
- Lead sponsor
- Prothya Biosolutions
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2007
- Completion date
- July 31, 2014
- Enrollment
- 55 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.